ArticleEye (London, England)2015
Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data.
Article in Eye (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 35 citations in OpenAlex.
- Fast Progressors in Primary Open-Angle Glaucoma: A 5-Year Visual Field Index-Based Classification in a Real-World Cohort.Ophthalmology and therapy · 2026Article
- Structural and Functional Progression in Open-Angle Glaucoma with Unilateral Peripapillary Intrachoroidal Cavitation.Journal of clinical medicine · 2026Article
- Proportion of Fast Progressors in the Central versus Global Visual Field Across Varying Glaucoma Severity Groups.American journal of ophthalmology · 2026Article
- Forecasting trends in glaucoma medication reimbursees in Finland: updated system dynamics model to 2070.BMJ open ophthalmology · 2025Article
- Prototype master protocol for benchmarking of real-world follow-up data in glaucoma.Acta ophthalmologica · 2025Article
- The value of virtual glaucoma clinics: a review.Eye (London, England) · 2024Review
- Measures of multiple deprivation and visual field loss in glaucoma clinics in England: lessons from big data.Eye (London, England) · 2023Article
- Clinical risk stratification in glaucoma.Eye (London, England) · 2023Review
- Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss.Ophthalmology · 2023Observational
- 24-Hour Monitoring of Intraocular Pressure Fluctuations Using a Contact Lens Sensor: Diagnostic Performance for Glaucoma Progression.Investigative ophthalmology & visual science · 2023Article
- Effect of Testing Frequency on the Time to Detect Glaucoma Progression With Optical Coherence Tomography (OCT) and OCT Angiography.American journal of ophthalmology · 2023Observational
- Does eye examination order for standard automated perimetry matter?Acta ophthalmologica · 2019Article
- Remote Grading of the Anterior Chamber Angle Using Goniophotographs and Optical Coherence Tomography: Implications for Telemedicine or Virtual Clinics.Translational vision science & technology · 2019Article
- Auditing service delivery in glaucoma clinics using visual field records: a feasibility study.BMJ open ophthalmology · 2019Article
- A New Graphical Tool for Assessing Visual Field Progression in Clinical Populations.Translational vision science & technology · 2018Article
- More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.BMC health services research · 2016Article
- Prevalence of Glu323Lys Mutation of theJournal of current glaucoma practiceArticle
- Functional assessment of glaucoma: Uncovering progression.Survey of ophthalmologyReview
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine changes in rates of visual field (VF) progression in patients attending a sample of glaucoma clinics in England between 1999 and 2012.
methodsAn archive of 473 252 Humphrey VFs recorded across the UK was retrospectively examined. Distribution of rates recorded in the first half of the decade was compared with the second. The relationship between age and severity of MD loss at baseline with rates of loss and frequency of testing was examined.
resultsVF series from 18 926 eyes were analysed. Median rate of MD loss for the period before and after 2003 was -0.11 and -0.06 dB/year, respectively, but the proportion of eyes with medium or fast rates of MD loss remained constant. Median rate of MD loss in older (>70 years) eyes was faster than that observed in younger (<60 years) eyes (-0.21 compared with -0.01 dB/year). Median rate of loss did not vary with severity of MD loss at baseline. Frequency of testing, typically carried out annually, did not vary by age, rate of loss or disease severity.
conclusionsVFs of eyes treated in the first half of the decade deteriorated more rapidly than those in the second half. Several factors might explain these differences but average effects were small and there was no reduction in the proportion of rapidly progressing eyes over the decade. Older age and, to a lesser extent, worse VF damage at diagnosis are indicators for faster VF loss in clinics, but frequency of VF testing was similar for all patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.